A novel monkey proarrhythmia model that can predict the drug-induced torsades de pointes in clinical practice

被引：0
|
作者：
Satoh, Y
Sugiyama, A
Takahara, A
Sakamoto, K
Sakamoto, M
Nomura, M
Hashimoto, K
机构：
[1] Univ Yamanashi, Dept Pharmacol, Yamanashi 4093898, Japan
[2] Koshu Rehabil Hosp, Yamanashi 4060032, Japan
[3] Yamanashi Res Ctr Clin Pharmacol, Yamanashi 4060023, Japan
[4] Ina Res Inc, Safety Res Ctr, Nagano 3994501, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：223P / 223P
页数：1
相关论文
共 50 条
  • [1] Use of preclinical assays to predict risk of drug-induced torsades de pointes
    Belardinelli, L
    Shryock, JC
    Wu, L
    Song, YJ
    HEART RHYTHM, 2005, 2 : S16 - S22
  • [2] Cellular basis of drug-induced torsades de pointes
    Roden, D. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (07) : 1502 - 1507
  • [3] Drug-Induced Torsades de Pointes and Genetic Screening
    Noheria, Amit
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 560 - 561
  • [4] Drug-induced Torsades de Pointes and implications for drug development
    Fenichel, RR
    Malik, M
    Antzelevitch, C
    Sanguinetti, M
    Roden, DM
    Priori, SG
    Ruskin, JN
    Lipicky, RJ
    Cantilena, LR
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (04) : 475 - 495
  • [5] Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes
    Sager, P. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (07) : 1544 - 1549
  • [6] Early clinical development: Evaluation of drug-induced torsades de pointes risk
    Vik, Torbjorn
    Pollard, Chris
    Sager, Philip
    PHARMACOLOGY & THERAPEUTICS, 2008, 119 (02) : 210 - 214
  • [7] Drug-induced torsades de pointes: The evolving role of pharmacogenetics
    Fitzgerald, PT
    Ackerman, MJ
    HEART RHYTHM, 2005, 2 : S30 - S37
  • [8] Drug-Induced Torsades de Pointes and Genetic Screening Reply
    Gupta, Arjun
    Pandey, Ambarish
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 561 - 561
  • [9] Understanding drug-induced torsades de pointes: a genetic stance
    Kannankeril, Prince J.
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (03) : 231 - 239
  • [10] Termination of drug-induced torsades de pointes with overdrive pacing
    Charlton, Nathan P.
    Lawrence, David T.
    Brady, William J.
    Kirk, Mark A.
    Holstege, Christopher P.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (01): : 95 - 102
12345